Kadimastem KMSTF Stock
Kadimastem Price Chart
Kadimastem KMSTF Financial and Trading Overview
Kadimastem stock price | 5.06 USD |
Previous Close | 0.65 USD |
Open | 0.65 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.65 - 0.65 USD |
52 Week Range | 0.65 - 0.65 USD |
Volume | 400 USD |
Avg. Volume | 0 USD |
Market Cap | 23.66M USD |
Beta (5Y Monthly) | 0.69863 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.73 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
KMSTF Valuation Measures
Enterprise Value | 27.26M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Kadimastem Stock Price History
Beta (5Y Monthly) | 0.69863 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.65 USD |
52 Week Low | 0.65 USD |
50-Day Moving Average | 0.65 USD |
200-Day Moving Average | 0.65 USD |
KMSTF Share Statistics
Avg. Volume (3 month) | 0 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 36.41M |
Float | 12M |
Short Ratio | N/A |
% Held by Insiders | 64.23% |
% Held by Institutions | 10.95% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -69.072% |
Return on Equity (ttm) | -289.25% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | -0.23 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | 2187.42 USD |
Current Ratio (mrq) | 0.704 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Kadimastem
Country | United States |
State | N/A |
City | Ness Ziona |
Address | Pinchas Sapir 7 |
ZIP | 74140 |
Phone | 972 73 797 1600 |
Website | https://www.kadimastem.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 31 |
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.
Q&A For Kadimastem Stock
What is a current KMSTF stock price?
Kadimastem KMSTF stock price today per share is 5.06 USD.
How to purchase Kadimastem stock?
You can buy KMSTF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kadimastem?
The stock symbol or ticker of Kadimastem is KMSTF.
Which industry does the Kadimastem company belong to?
The Kadimastem industry is Biotechnology.
How many shares does Kadimastem have in circulation?
The max supply of Kadimastem shares is 6.07M.
What is Kadimastem Price to Earnings Ratio (PE Ratio)?
Kadimastem PE Ratio is now.
What was Kadimastem earnings per share over the trailing 12 months (TTM)?
Kadimastem EPS is -1.73 USD over the trailing 12 months.
Which sector does the Kadimastem company belong to?
The Kadimastem sector is Healthcare.